Ann: Imugene HER-Vaxx Phase 2 Clinical Update, page-2

  1. 14,247 Posts.
    lightbulb Created with Sketch. 4256
    Imugene’s MD & CEO, Mrs Leslie Chong said, “I am happy to report that we have achieved this
    significant milestone and I’m highly encouraged by the positive outcome of this first IDMC
    meeting. I am truly pleased with the study progress to date.”


    Can't wait for the " -622 DOW - sell,sell,sell - holders " to sell them cheaper to me today.

    GLTA and especially sufferers - a bit closer to the cure - Yeah !!!!!!!!!

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.3¢
Change
-0.023(7.63%)
Mkt cap ! $77.89M
Open High Low Value Volume
29.5¢ 29.5¢ 27.0¢ $626.5K 2.248M

Buyers (Bids)

No. Vol. Price($)
28 397342 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 234280 4
View Market Depth
Last trade - 13.29pm 29/07/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.